Add to ORKGAtlanta Conference on Science and Innovation Policy 2009This presentation was part of the session : Organizations of Science and InnovationEuropean Commission; UMass Lowell; The Open University (UK
Biotechnology investment, in the second quarter of 2015, hauled in a record $2.3 billion worth of ve...
Recent studies have highlighted a reduction in projected financial returns associated with biopharma...
In this study, we investigate the development of biotechnology from academic entrepreneurship to ind...
The biotechnology and pharmaceutical industries are facing significant challenges to their existing ...
Abstract: This paper surveys financial issues that characterise the US biotechnology scenario. They ...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Electrical Engineering and Comp...
Driven by the perspective of maximizing shareholder value (MSV), the U.S. biopharmaceutical industry...
This article explores how the UK's biotech firms have evolved in response to their financial environ...
Wooding of the University of Massachusetts Lowell for supporting this project. Funding ha
Thesis: S.M. in Technology and Policy, Massachusetts Institute of Technology, School of Engineering,...
A substantial amount of research has been committed to exploring how university-based research can b...
Biotechnology refers to the large and growing array of scientific tools that use living cells and th...
This study analyzes the relationship between the amount of research and development (R&D) spendi...
Supported by a grant from the Kaiser Family Foundation and by funds from the RCA Corporation.Bibliog...
Innovative biotechnology firms (hereafter, biotechs or biotech firms) consider drug development alli...
Biotechnology investment, in the second quarter of 2015, hauled in a record $2.3 billion worth of ve...
Recent studies have highlighted a reduction in projected financial returns associated with biopharma...
In this study, we investigate the development of biotechnology from academic entrepreneurship to ind...
The biotechnology and pharmaceutical industries are facing significant challenges to their existing ...
Abstract: This paper surveys financial issues that characterise the US biotechnology scenario. They ...
Thesis: Ph. D., Massachusetts Institute of Technology, Department of Electrical Engineering and Comp...
Driven by the perspective of maximizing shareholder value (MSV), the U.S. biopharmaceutical industry...
This article explores how the UK's biotech firms have evolved in response to their financial environ...
Wooding of the University of Massachusetts Lowell for supporting this project. Funding ha
Thesis: S.M. in Technology and Policy, Massachusetts Institute of Technology, School of Engineering,...
A substantial amount of research has been committed to exploring how university-based research can b...
Biotechnology refers to the large and growing array of scientific tools that use living cells and th...
This study analyzes the relationship between the amount of research and development (R&D) spendi...
Supported by a grant from the Kaiser Family Foundation and by funds from the RCA Corporation.Bibliog...
Innovative biotechnology firms (hereafter, biotechs or biotech firms) consider drug development alli...
Biotechnology investment, in the second quarter of 2015, hauled in a record $2.3 billion worth of ve...
Recent studies have highlighted a reduction in projected financial returns associated with biopharma...
In this study, we investigate the development of biotechnology from academic entrepreneurship to ind...